- - Thursday, December 22, 2011

MISSOURI

Wal-Mart pulls formula after baby’s death

COLUMBIA | Wal-Mart and health officials awaited tests Thursday on a batch of powdered infant formula that was removed from more than 3,000 stores nationwide after a Missouri newborn who consumed it apparently died from a rare infection.

The source of the bacteria that caused the infection has not been determined, but it occurs naturally in the environment and in plants such as wheat and rice. The most worrisome appearances have been in dried milk and powdered formula, which is why manufacturers routinely test for the germs.

Wal-Mart pulled the Enfamil Newborn formula from shelves as a precaution after the death of Avery Cornett in the town of Lebanon.

The formula has not been recalled, and the manufacturer said tests showed the batch was negative for the bacteria before it was shipped. Additional tests were under way.

“We decided it was best to remove the product until we learn more,” Wal-Mart spokeswoman Dianna Gee said. “It could be returned to the shelves.”

Customers who bought formula in 12.5-ounce cans with the lot number ZP1K7G have the option of returning them for a refund or exchange, she said.

The product is not exclusive to Wal-Mart. The manufacturer, Mead Johnson Nutrition, declined to answer questions about whether formula from that batch was distributed to other stores.

“We’re highly confident in the safety and quality of our products,” said Christopher Perille, a spokesman for the company based in the Chicago suburb of Glenview.

A second infant fell ill after consuming powdered baby formula in the last month, but that child recovered, state health officials said.

OHIO

Danish company sells drug used in executions

COLUMBUS | The only U.S.-licensed maker of a drug used by several states to execute inmates is selling the product to another drug manufacturer.

Denmark-based Lundbeck Inc. says a distribution system meant to keep the drug out of the hands of prisons will remain in place as Lake Forest, Ill.-based Akorn Inc. acquires the drug.

Story Continues →